ACM
WST icon

Atika Capital Management’s West Pharmaceutical WST Stock Holding History

Atika Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,000
Closed -$2.47M – 147
2020
Q3 		$2.47M Buy
+9,000
New +$2.38M 0.2% 94

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Atika Capital Management's WST Position: Q4 2020 in Review

Atika Capital Management sold out of West Pharmaceutical (WST) in Q4 2020, closing a stake of 9,000 shares — an estimated $2.47M sold.

Atika Capital Management first reported a position in WST in Q3 2020 and held it in 1 quarter. The position peaked at $2.47M in Q3 2020. 592 funds tracked by Wall St. Rank hold WST as of Q4 2020.

  • Atika Capital Management reported no remaining West Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Atika Capital Management sold 9,000 West Pharmaceutical shares in Q4 2020, an estimated $2.47M.
  • Atika Capital Management first reported a position in West Pharmaceutical in Q3 2020 and held it in 1 quarter.
  • Atika Capital Management's West Pharmaceutical position peaked at $2.47M in Q3 2020.
  • 592 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Atika Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.